Tony Tipton appointed as Crossject’s US Operations Director to commercialize ZEPIZURE®, an emergency treatment for epileptic seizures – 08/19/2024 at 6:48 p.m.
Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceutical company developing emergency medicines delivered with its award-winning ZENEO® needle-free auto-injector, announces the appointment of veteran healthcare executive Tony Tipton as Chief Operating Officer, U.S. With over 25 years of experience in key sectors of the commercial pharmaceutical industry, he brings expertise in corporate governance and development, … Read more